Issue contents
Download PDF of article
Download CIF
3D view
Navigation
Highlighting
Dictionary of Crystallography reference
IUPAC Gold Book reference
more ...
Download citation
FormatBIBTeX
EndNote
RefMan
Refer
Medline
CIF
SGML
Plain Text
share
Previous article
Next article
Previous article
Issue contents
Download PDF of article
Download CIF
3D view
Navigation
Highlighting
Dictionary of Crystallography reference
IUPAC Gold Book reference
more ...
Download citation
FormatBIBTeX
EndNote
RefMan
Refer
Medline
CIF
SGML
Plain Text
share
Next article

organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 64| Part 6| June 2008| Page o1056
doi:10.1107/S1600536808013366

1-Phenyl-6,7,8,9-hexa­hydro-1H,5H-cyclo­hepta­[1′,2′:2,3]pyrido[6,5-c]pyrazol-4-amine: a new tacrine analogue

Lijun Zhang,a Daxin Shi,a Jiarong Li,a* Ling Zhanga and Yanqiu Fana

aSchool of Chemical Engineering and the Environment, Beijing Institute of Technology, Beijing 100081, People's Republic of China
*Correspondence e-mail: cdlijun@bit.edu.cn

(Received 14 April 2008; accepted 6 May 2008; online 10 May 2008)

The title compound, C17H18N4, contains a pyrazolopyridine system fused with a seven-membered carbocyclic ring. The pyrazole ring is coplanar with the pyridine ring, while the phenyl ring is twisted by a dihedral angle of 14.38 (14)° with respect to the pyridine ring. The seven-membered ring displays a chair conformation. The packing is stabilized by N—H⋯N hydrogen bonds and N—H⋯π(arene) inter­actions.

Related literature

For related literature, see: Gracon et al. (1998[Gracon, S. I., Knapp, M. J., Berghoff, W. G., Pierce, M., DeJong, R., Lobbestael, S. J., Symons, J., Dombey, S. L., Luscombe, F. A. & Kraemer, D. (1998). Alzheimer Dis. Assoc. Disord. 12, 93-101.]); Haviv et al. (2005[Haviv, H., Wong, D. M., Greenblatt, H. M., Carlier, P. R., Han, Y. F., Pang, Y. P., Silman, I. & Sussman, J. L. (2005). J. Am. Chem. Soc. 127, 11029-11036.]); Kelley et al. (1988[Kelley, J. L., Krochmal, M. P., Linn, J. A., McLean, E. W. & Soroko, F. E. (1988). J. Med. Chem. 31, 1005-1009.]); Kim et al. (1996[Kim, Y. C., Ji, X. D. & Jacobson, K. A. (1996). J. Med. Chem. 39, 4142-4148.]); Lin et al. (2007[Lin, R., Connolly, P., Chiu, G., Yu, Y., Li, S., Emanuel, S. & Greenberger, L. (2007). 234th ACS National Meeting, Boston, August 19-23.]); Stachlewitz et al. (1997[Stachlewitz, R. F., Arteel, G. E., Raleigh, J. A., Connor, H. D., Mason, R. P. & Thurman, R. G. J. (1997). J. Pharmacol. Exp. Ther. 282, 1591-1599.]); Zocchi et al. (1996[Zocchi, C., Ongini, E., Conti, A., Monopoli, A., Negretti, A., Baraldi, P. G. & Dionisotti, S. (1996). J. Pharmacol. Exp. Ther. 276, 398-404.]); Erast et al. (1987[Erast, B., Bend, Z. & Norbert, M. (1987). German Patent DE 3 604 569.]).

[Scheme 1]

Experimental

Crystal data

  • C17H18N4

  • Mr = 278.35

  • Monoclinic, P 21 /a

  • a = 13.694 (13) Å

  • b = 6.888 (6) Å

  • c = 16.929 (16) Å

  • β = 112.417 (12)°

  • V = 1476 (2) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 0.08 mm−1

  • T = 293 (2) K

  • 0.24 × 0.18 × 0.10 mm
Data collection

  • Rigaku Saturn diffractometer

  • Absorption correction: multi-scan (Jacobson, 1998[Jacobson, R. (1998). Private communication to the Rigaku Corporation, Tokyo, Japan.]) Tmin = 0.982, Tmax = 0.992

  • 10708 measured reflections

  • 2593 independent reflections

  • 2004 reflections with I > 2σ(I)

  • Rint = 0.045
Refinement

  • R[F2 > 2σ(F2)] = 0.064

  • wR(F2) = 0.162

  • S = 1.13

  • 2593 reflections

  • 190 parameters

  • H-atom parameters constrained

  • Δρmax = 0.13 e Å−3

  • Δρmin = −0.16 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A D⋯A D—H⋯A
N1—H1B⋯N4i 0.86 2.28 3.139 (4) 175
N1—H1A⋯Cg1ii 0.86 2.84 3.608 (4) 150
Symmetry codes: (i) [-x+{\script{1\over 2}}, y-{\script{1\over 2}}, -z]; (ii) [x-{\script{3\over 2}}, -y-{\script{1\over 2}}, z]. Cg1 is the centroid of the benzene ring.

Data collection: CrystalClear (Rigaku, 2004[Rigaku (2004). CrystalClear. Rigaku Corporation, Tokyo, Japan.]); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEPIII (Burnett & Johnson, 1996[Burnett, M. N. & Johnson, C. K. (1996). ORTEPIII. Report ORNL-6895. Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.]), ORTEP-3 for Windows (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]) and PLATON (Spek, 2003[Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.]); software used to prepare material for publication: SHELXL97.

Supporting information

Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536808013366/dn2339sup1.cif

Structure factors: contains datablock I. DOI: 10.1107/S1600536808013366/dn2339Isup2.hkl

checkCIF report


Comment top

Tacrine (9-amino-1,2,3,4-tetrahydroacridine, THA) was the first acetylcholinesterase inhibitor approved for the palliative treatment of Alzheimer's disease (AD) (Gracon et al., 1998). But due to its undesirable side effects, especially its hepatotoxicity, the clinical usefulness is limited (Stachlewitz et al., 1997), and the research on seeking new AChE inhibitors with improved activity and reduced adverse side effects are progressing (Haviv et al., 2005). In view of the considerable biological and medicinal activities of pyrazole ring compounds, such as important adenosine antagonist (Zocchi et al., 1996), antifungals (Kim et al., 1996), plant growth regulators (Erast et al., 1987), anti-tumor agents (Lin et al., 2007), anticonvulsant agents (Kelley et al., 1988), etc. we designed and synthesized the compound 11-phenyl-1,5,6,7,8,9- hexahydrocyclohepta[b]pyrazolo[4,3-e]-pyridin-4-amine (a new Tacrine analogue) (Scheme 1).

In the title compound, the fused pyrazolopyridine moiety is roughly coplanar, with an angle of 1.4° between the pyrazole and the pyridine rings (Fig. 1), The largest deviation from the mean plane being 0.014 (2)Å at C5. Both the C3—N2 [1.345 (3) Å] and the C4—N2 [1.348 (3) Å] bond lengths of pyridine are much shorter than those observed in the pyrazole ring [C3—N3 1.378 (3) Å and N3—N4 1.380 (3) Å], indicating higher aromatic nature of the pyridine ring than the pyrazole. The amino group is sligthly twisted by 1.71 (8)° with respect to the pyrazolopyridine moiety The benzene is also twisted and make a dihedral angle of 14.38 (14)\% with the pyrazolopyridine moiety, The seven-membered ring displays a chair conformation.

There are strong intermolecular N—H···N hydrogen bonds between the amino group and one N atom of the pyrazole ring (Table 1, Fig. 2). The packing is further stabilized by N—H···π(benzene) interactions (Table 1).

Related literature top

For related literature, see: Gracon et al. (1998); Haviv et al. (2005); Kelley et al. (1988); Kim et al. (1996); Lin et al. (2007); Stachlewitz et al. (1997); Zocchi et al. (1996); Erast et al. (1987). Cg1 is the centroid of the benzene ring.

Experimental top

A solution of 0.2 g of 5-amino-4-cyanopyrazole (1.1 mmol,), 0.16 g of AlCl3 (1.2 mmol,) in 5 ml of 1,2-dichloroethane was refluxed for 4 h (monitored by TLC). The reaction mixture was cooled, dispersed into THF/water (2:1 vol.) and titrated to pH=7 by 20% sodium hydroxide. Then, the mixture was stirred for 30 min. and extracted three times with dichloromethane, the organic layers were dried and evaporated at reduced pressure to give the solid product (Fig. 3). The title compound 1 was purified by silica gel column chromatography eluting with ethyl acetate/light petroleum in 40% yield.

Its single-crystal was cultured from a solution of ethanol by slow evaporation at room temperature.

The product 1, white crystal, m.p. 194–195°C, was characterized by 1H NMR, 13C NMR, ESI, IR, EA. IR (KBr) (cm-1): 3482 and 3350 (NH), 2922 (CH), 1638 and 1594 (C=N), 1501, 1358; 1H NMR (400 MHz, CDCl3, δp.p.m.): 1.62–1.90 (m, 6H, alkyl-H), 2.66–2.69 (t, 2H, alkyl-H), 3.08–3.01 (t, 2H, alkyl-H), 4.60 (s, 2H, NH2), 7.22–7.26 (t, J=7.4 Hz, 1H), 7.46–7.50 (t, J=7.5 Hz, 2H), 7.98 (s, 1H), 8.30–8.32 (d, J=7.6 Hz, 2H); 13C NMR (400 MHz, CDCl3, δp.p.m.): 25.40, 26.79, 27.56, 32.16, 39.81, 106.11, 113.24, 120.91 (2 C), 125.37, 128.89 (2 C), 130.61, 140.02, 143.69, 149.52, 165.25; ESI [M+H]+: 279.1; Anal. Calcd. for C17H18N4: C, 73.35; H, 6.52; N, 20.13. Found: C, 73.17; H, 6.52; N, 19.99.

Refinement top

All H atoms attached to C atoms were fixed geometrically and treated as riding with C—H = 0.93 Å (aromatic) or 0.98 Å (methine) with Uiso(H) = 1.2Ueq(C). H atoms attached to N were located in difference Fourier maps but introduced in calculated positions and treated as riding on the N atoms with N-H = 0.86 Å and Uiso(H) = 1.2Ueq(N).

Computing details top

Data collection: CrystalClear (Rigaku, 2004); cell refinement: CrystalClear (Rigaku, 2004); data reduction: CrystalClear (Rigaku, 2004); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEPIII (Burnett & Johnson, 1996), ORTEP-3 for Windows (Farrugia, 1997) and PLATON (Spek, 2003); software used to prepare material for publication: SHELXL97 (Sheldrick, 2008).

Figures top
[Figure 1] Fig. 1. The molecular structure of the title compound, with the atom- labelling scheme. Displacement ellipsoids are drawn at the 30% probability level. H atoms are represented as small spheres of arbitrary radii.
[Figure 2] Fig. 2. Partial packing view showing as dashed lines the N-H···N hydrogen bondings. H atoms not involved in hydrogen bonds have been omitted for clarity. [Symmetry code: (i) -x+1/2, y-1/2, -z]
[Figure 3] Fig. 3. Reaction pathway for the synthesis of the title compound.
1-Phenyl-6,7,8,9-hexahydro-1H,5H-cyclohepta[1',2':2,3]pyrido[6,5-c]pyrazol- 4-amine top
Crystal data top
C17H18N4F(000) = 592
Mr = 278.35Dx = 1.252 Mg m−3
Monoclinic, P21/aMo Kα radiation, λ = 0.71070 Å
Hall symbol: -P 2yabCell parameters from 2169 reflections
a = 13.694 (13) Åθ = 2.6–27.9°
b = 6.888 (6) ŵ = 0.08 mm−1
c = 16.929 (16) ÅT = 293 K
β = 112.417 (12)°Platelet, colorless
V = 1476 (2) Å30.24 × 0.18 × 0.10 mm
Z = 4
Data collection top
Rigaku Saturn
diffractometer		2593 independent reflections
Radiation source: rotating anode2004 reflections with I > 2σ(I)
Confocal monochromatorRint = 0.045
Detector resolution: 7.31 pixels mm-1θmax = 25.0°, θmin = 1.3°
ω scansh = −16→16
Absorption correction: multi-scan
(Jacobson, 1998)		k = −8→8
Tmin = 0.982, Tmax = 0.992l = −20→20
10708 measured reflections
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.064Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.162H-atom parameters constrained
S = 1.13 w = 1/[σ2(Fo2) + (0.0737P)2 + 0.1595P]
where P = (Fo2 + 2Fc2)/3
2593 reflections(Δ/σ)max = 0.001
190 parametersΔρmax = 0.13 e Å−3
0 restraintsΔρmin = −0.16 e Å−3
Crystal data top
C17H18N4V = 1476 (2) Å3
Mr = 278.35Z = 4
Monoclinic, P21/aMo Kα radiation
a = 13.694 (13) ŵ = 0.08 mm−1
b = 6.888 (6) ÅT = 293 K
c = 16.929 (16) Å0.24 × 0.18 × 0.10 mm
β = 112.417 (12)°
Data collection top
Rigaku Saturn
diffractometer		2593 independent reflections
Absorption correction: multi-scan
(Jacobson, 1998)		2004 reflections with I > 2σ(I)
Tmin = 0.982, Tmax = 0.992Rint = 0.045
10708 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0640 restraints
wR(F2) = 0.162H-atom parameters constrained
S = 1.13Δρmax = 0.13 e Å−3
2593 reflectionsΔρmin = −0.16 e Å−3
190 parameters
Special details top

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
N10.22712 (17)−0.0370 (3)0.14030 (12)0.0759 (7)
H1A0.2063−0.12880.16450.091*
H1B0.2046−0.03150.08550.091*
N20.43578 (14)0.4015 (3)0.28441 (11)0.0555 (5)
N30.41678 (14)0.5193 (3)0.14393 (11)0.0561 (5)
N40.36441 (16)0.4614 (3)0.06027 (11)0.0659 (6)
C10.29571 (17)0.0997 (3)0.18869 (13)0.0520 (6)
C20.32949 (16)0.2498 (3)0.14847 (13)0.0506 (6)
C30.39672 (16)0.3917 (3)0.19859 (13)0.0497 (5)
C40.40415 (17)0.2541 (3)0.32127 (13)0.0536 (6)
C50.33628 (16)0.1021 (3)0.27801 (13)0.0517 (6)
C60.31279 (19)0.3022 (4)0.06373 (14)0.0633 (7)
H60.27030.23250.01590.076*
C70.47904 (17)0.6919 (3)0.16101 (15)0.0553 (6)
C80.5064 (2)0.7724 (4)0.09698 (17)0.0709 (7)
H80.48370.71540.04320.085*
C90.5679 (2)0.9391 (4)0.1146 (2)0.0841 (9)
H90.58620.99380.07190.101*
C100.6020 (2)1.0244 (4)0.1935 (2)0.0856 (9)
H100.64341.13590.20450.103*
C110.5746 (2)0.9436 (4)0.25592 (19)0.0801 (8)
H110.59731.00130.30960.096*
C120.51355 (18)0.7772 (4)0.24043 (16)0.0650 (7)
H120.49590.72320.28360.078*
C130.4445 (2)0.2642 (4)0.41739 (14)0.0737 (8)
H13A0.49700.36650.43710.088*
H13B0.47910.14260.44090.088*
C140.3584 (2)0.3027 (4)0.45167 (17)0.0882 (9)
H14A0.39080.35920.50820.106*
H14B0.31000.39820.41520.106*
C150.2955 (2)0.1271 (5)0.45736 (17)0.0860 (9)
H15A0.24470.16770.48120.103*
H15B0.34330.03590.49710.103*
C160.2365 (2)0.0213 (4)0.37396 (15)0.0755 (8)
H16A0.18360.10810.33590.091*
H16B0.1997−0.08860.38560.091*
C170.3059 (2)−0.0518 (4)0.32817 (15)0.0671 (7)
H17A0.3699−0.10660.37020.081*
H17B0.2689−0.15520.28940.081*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
N10.0947 (16)0.0801 (15)0.0543 (12)−0.0340 (12)0.0301 (12)−0.0143 (10)
N20.0539 (11)0.0634 (12)0.0483 (11)−0.0081 (9)0.0185 (9)−0.0006 (9)
N30.0578 (12)0.0610 (12)0.0471 (11)−0.0037 (9)0.0173 (9)0.0050 (9)
N40.0722 (14)0.0747 (14)0.0465 (11)−0.0064 (11)0.0178 (10)0.0053 (10)
C10.0523 (13)0.0573 (13)0.0484 (12)−0.0041 (11)0.0214 (11)−0.0058 (10)
C20.0503 (13)0.0581 (14)0.0429 (12)0.0013 (11)0.0171 (10)0.0002 (10)
C30.0476 (13)0.0577 (13)0.0447 (12)−0.0002 (11)0.0186 (10)0.0035 (10)
C40.0493 (13)0.0676 (15)0.0439 (12)−0.0047 (11)0.0177 (10)0.0006 (10)
C50.0530 (13)0.0555 (13)0.0485 (12)−0.0017 (11)0.0217 (10)0.0010 (10)
C60.0683 (16)0.0724 (16)0.0447 (13)−0.0090 (13)0.0166 (11)−0.0012 (11)
C70.0480 (13)0.0531 (13)0.0633 (14)0.0038 (11)0.0195 (11)0.0097 (11)
C80.0694 (16)0.0731 (17)0.0712 (16)0.0035 (14)0.0278 (14)0.0164 (13)
C90.081 (2)0.0758 (19)0.103 (2)−0.0069 (16)0.0428 (18)0.0252 (17)
C100.081 (2)0.0668 (18)0.110 (2)−0.0146 (15)0.0371 (18)0.0020 (17)
C110.0773 (19)0.0689 (17)0.096 (2)−0.0126 (14)0.0348 (16)−0.0040 (15)
C120.0638 (16)0.0633 (16)0.0712 (16)−0.0039 (12)0.0294 (13)0.0000 (12)
C130.0709 (17)0.098 (2)0.0462 (13)−0.0243 (15)0.0163 (12)−0.0020 (13)
C140.111 (2)0.102 (2)0.0664 (17)−0.0358 (18)0.0502 (17)−0.0252 (15)
C150.098 (2)0.106 (2)0.0694 (17)−0.0220 (18)0.0490 (17)−0.0144 (15)
C160.0798 (18)0.0903 (19)0.0643 (16)−0.0226 (15)0.0364 (14)−0.0022 (14)
C170.0829 (18)0.0652 (16)0.0568 (14)−0.0123 (13)0.0305 (13)−0.0004 (12)
Geometric parameters (Å, º) top
N1—C11.361 (3)C9—C101.368 (4)
N1—H1A0.8600C9—H90.9300
N1—H1B0.8600C10—C111.369 (4)
N2—C31.345 (3)C10—H100.9300
N2—C41.347 (3)C11—C121.383 (3)
N3—C31.377 (3)C11—H110.9300
N3—N41.380 (3)C12—H120.9300
N3—C71.427 (3)C13—C141.523 (4)
N4—C61.318 (3)C13—H13A0.9700
C1—C51.398 (3)C13—H13B0.9700
C1—C21.410 (3)C14—C151.508 (4)
C2—C31.388 (3)C14—H14A0.9700
C2—C61.411 (3)C14—H14B0.9700
C4—C51.406 (3)C15—C161.519 (4)
C4—C131.507 (3)C15—H15A0.9700
C5—C171.512 (3)C15—H15B0.9700
C6—H60.9300C16—C171.523 (3)
C7—C121.375 (3)C16—H16A0.9700
C7—C81.390 (3)C16—H16B0.9700
C8—C91.388 (4)C17—H17A0.9700
C8—H80.9300C17—H17B0.9700
C1—N1—H1A120.0C11—C10—H10120.4
C1—N1—H1B120.0C10—C11—C12121.0 (3)
H1A—N1—H1B120.0C10—C11—H11119.5
C3—N2—C4113.38 (18)C12—C11—H11119.5
C3—N3—N4110.27 (19)C7—C12—C11119.8 (2)
C3—N3—C7130.71 (19)C7—C12—H12120.1
N4—N3—C7119.02 (18)C11—C12—H12120.1
C6—N4—N3105.81 (18)C4—C13—C14113.6 (2)
N1—C1—C5123.9 (2)C4—C13—H13A108.8
N1—C1—C2119.7 (2)C14—C13—H13A108.8
C5—C1—C2116.4 (2)C4—C13—H13B108.8
C3—C2—C1118.98 (19)C14—C13—H13B108.8
C3—C2—C6104.73 (19)H13A—C13—H13B107.7
C1—C2—C6136.3 (2)C15—C14—C13115.4 (2)
N2—C3—N3126.5 (2)C15—C14—H14A108.4
N2—C3—C2126.41 (19)C13—C14—H14A108.4
N3—C3—C2107.11 (19)C15—C14—H14B108.4
N2—C4—C5125.8 (2)C13—C14—H14B108.4
N2—C4—C13114.5 (2)H14A—C14—H14B107.5
C5—C4—C13119.6 (2)C14—C15—C16116.1 (2)
C1—C5—C4118.92 (19)C14—C15—H15A108.3
C1—C5—C17121.2 (2)C16—C15—H15A108.3
C4—C5—C17119.9 (2)C14—C15—H15B108.3
N4—C6—C2112.1 (2)C16—C15—H15B108.3
N4—C6—H6124.0H15A—C15—H15B107.4
C2—C6—H6124.0C15—C16—C17114.7 (2)
C12—C7—C8119.8 (2)C15—C16—H16A108.6
C12—C7—N3120.7 (2)C17—C16—H16A108.6
C8—C7—N3119.5 (2)C15—C16—H16B108.6
C9—C8—C7119.0 (3)C17—C16—H16B108.6
C9—C8—H8120.5H16A—C16—H16B107.6
C7—C8—H8120.5C5—C17—C16114.4 (2)
C10—C9—C8121.2 (3)C5—C17—H17A108.7
C10—C9—H9119.4C16—C17—H17A108.7
C8—C9—H9119.4C5—C17—H17B108.7
C9—C10—C11119.2 (3)C16—C17—H17B108.7
C9—C10—H10120.4H17A—C17—H17B107.6
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N1—H1B···N4i0.862.283.139 (4)175
N1—H1A···Cg1ii0.862.843.608 (4)150
Symmetry codes: (i) −x+1/2, y−1/2, −z; (ii) x−3/2, −y−1/2, z.

Experimental details

Crystal data
Chemical formulaC17H18N4
Mr278.35
Crystal system, space groupMonoclinic, P21/a
Temperature (K)293
a, b, c (Å)13.694 (13), 6.888 (6), 16.929 (16)
β (°) 112.417 (12)
V (Å3)1476 (2)
Z4
Radiation typeMo Kα
µ (mm−1)0.08
Crystal size (mm)0.24 × 0.18 × 0.10
Data collection
DiffractometerRigaku Saturn
diffractometer
Absorption correctionMulti-scan
(Jacobson, 1998)
Tmin, Tmax0.982, 0.992
No. of measured, independent and
observed [I > 2σ(I)] reflections		10708, 2593, 2004
Rint0.045
(sin θ/λ)max (Å−1)0.595
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.064, 0.162, 1.13
No. of reflections2593
No. of parameters190
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.13, −0.16

Computer programs: CrystalClear (Rigaku, 2004), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), ORTEPIII (Burnett & Johnson, 1996), ORTEP-3 for Windows (Farrugia, 1997) and PLATON (Spek, 2003).

Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N1—H1B···N4i0.862.283.139 (4)175.1
N1—H1A···Cg1ii0.862.843.608 (4)150
Symmetry codes: (i) −x+1/2, y−1/2, −z; (ii) x−3/2, −y−1/2, z.
 

Acknowledgements

We thank Beijing Institute of Technology for financial support and Naikai University for the X-ray diffraction analysis.

References

First citationBurnett, M. N. & Johnson, C. K. (1996). ORTEPIII. Report ORNL-6895. Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.  Google Scholar
 First citationErast, B., Bend, Z. & Norbert, M. (1987). German Patent DE 3 604 569.  Google Scholar
 First citationFarrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  CrossRef IUCr Journals Google Scholar
 First citationGracon, S. I., Knapp, M. J., Berghoff, W. G., Pierce, M., DeJong, R., Lobbestael, S. J., Symons, J., Dombey, S. L., Luscombe, F. A. & Kraemer, D. (1998). Alzheimer Dis. Assoc. Disord. 12, 93–101.  Web of Science CrossRef CAS PubMed Google Scholar
 First citationHaviv, H., Wong, D. M., Greenblatt, H. M., Carlier, P. R., Han, Y. F., Pang, Y. P., Silman, I. & Sussman, J. L. (2005). J. Am. Chem. Soc. 127, 11029–11036.  Web of Science CrossRef PubMed CAS Google Scholar
 First citationJacobson, R. (1998). Private communication to the Rigaku Corporation, Tokyo, Japan.  Google Scholar
 First citationKelley, J. L., Krochmal, M. P., Linn, J. A., McLean, E. W. & Soroko, F. E. (1988). J. Med. Chem. 31, 1005-1009.  CrossRef CAS PubMed Web of Science Google Scholar
 First citationKim, Y. C., Ji, X. D. & Jacobson, K. A. (1996). J. Med. Chem. 39, 4142-4148.  CrossRef CAS PubMed Web of Science Google Scholar
 First citationLin, R., Connolly, P., Chiu, G., Yu, Y., Li, S., Emanuel, S. & Greenberger, L. (2007). 234th ACS National Meeting, Boston, August 19–23.  Google Scholar
 First citationRigaku (2004). CrystalClear. Rigaku Corporation, Tokyo, Japan.  Google Scholar
 First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
 First citationSpek, A. L. (2003). J. Appl. Cryst. 36, 7–13.  Web of Science CrossRef CAS IUCr Journals Google Scholar
 First citationStachlewitz, R. F., Arteel, G. E., Raleigh, J. A., Connor, H. D., Mason, R. P. & Thurman, R. G. J. (1997). J. Pharmacol. Exp. Ther. 282, 1591–1599.  CAS PubMed Web of Science Google Scholar
 First citationZocchi, C., Ongini, E., Conti, A., Monopoli, A., Negretti, A., Baraldi, P. G. & Dionisotti, S. (1996). J. Pharmacol. Exp. Ther. 276, 398-404.  CAS PubMed Web of Science Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 64| Part 6| June 2008| Page o1056
doi:10.1107/S1600536808013366
Follow Acta Cryst. E
Sign up for e-alerts
E-alerts
Follow Acta Cryst. on Twitter
Twitter
Follow us on facebook
Facebook
Sign up for RSS feeds
RSS